232 related articles for article (PubMed ID: 12027978)
1. Systematic review of the use of fibrin sealant to minimize perioperative allogeneic blood transfusion.
Carless PA; Anthony DM; Henry DA
Br J Surg; 2002 Jun; 89(6):695-703. PubMed ID: 12027978
[TBL] [Abstract][Full Text] [Related]
2. Fibrin sealant use for minimising peri-operative allogeneic blood transfusion.
Carless PA; Henry DA; Anthony DM
Cochrane Database Syst Rev; 2003; 2003(2):CD004171. PubMed ID: 12804501
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model.
Davies L; Brown TJ; Haynes S; Payne K; Elliott RA; McCollum C
Health Technol Assess; 2006 Nov; 10(44):iii-iv, ix-x, 1-210. PubMed ID: 17049141
[TBL] [Abstract][Full Text] [Related]
4. Systematic review and meta-analysis of the use of fibrin sealant to prevent seroma formation after breast cancer surgery.
Carless PA; Henry DA
Br J Surg; 2006 Jul; 93(7):810-9. PubMed ID: 16775816
[TBL] [Abstract][Full Text] [Related]
5. Cell salvage for minimising perioperative allogeneic blood transfusion.
Carless PA; Henry DA; Moxey AJ; O'Connell DL; Fergusson DA
Cochrane Database Syst Rev; 2003; (4):CD001888. PubMed ID: 14583940
[TBL] [Abstract][Full Text] [Related]
6. [Fibrin sealants can reduce the use of blood transfusions in surgery. A status article based on the Cochrane analysis "Fibrin sealant use for minimising peri-operative blood transfusion"].
Kjaergård HK
Ugeskr Laeger; 2004 May; 166(23):2235-7. PubMed ID: 15487519
[No Abstract] [Full Text] [Related]
7. Desmopressin for minimising perioperative allogeneic blood transfusion.
Carless PA; Henry DA; Moxey AJ; O'Connell D; McClelland B; Henderson KM; Sly K; Laupacis A; Fergusson D
Cochrane Database Syst Rev; 2004; (1):CD001884. PubMed ID: 14973974
[TBL] [Abstract][Full Text] [Related]
8. Fibrin and Thrombin Sealants in Vascular and Cardiac Surgery: A Systematic Review and Meta-analysis.
Daud A; Kaur B; McClure GR; Belley-Cote EP; Harlock J; Crowther M; Whitlock RP
Eur J Vasc Endovasc Surg; 2020 Sep; 60(3):469-478. PubMed ID: 32620348
[TBL] [Abstract][Full Text] [Related]
9. Multicentre randomized clinical trial to investigate the cost-effectiveness of an allogeneic single-donor fibrin sealant after coronary artery bypass grafting (FIBER Study).
Tavilla G; Bruggemans EF; Gielen CL; Brand A; van den Hout WB; Klautz RJ; van Hilten JA
Br J Surg; 2015 Oct; 102(11):1338-47. PubMed ID: 26265447
[TBL] [Abstract][Full Text] [Related]
10. Effect of fibrin sealant on blood loss following total knee arthroplasty: a systematic review and meta-analysis.
Liu J; Cao JG; Wang L; Ma XL
Int J Surg; 2014; 12(2):95-102. PubMed ID: 24316285
[TBL] [Abstract][Full Text] [Related]
11. Cell salvage for minimising perioperative allogeneic blood transfusion.
Carless PA; Henry DA; Moxey AJ; O'connell DL; Brown T; Fergusson DA
Cochrane Database Syst Rev; 2006 Oct; (4):CD001888. PubMed ID: 17054147
[TBL] [Abstract][Full Text] [Related]
12. Desmopressin for minimising perioperative allogeneic blood transfusion.
Henry DA; Moxey AJ; Carless PA; O'Connell D; McClelland B; Henderson KM; Sly K; Laupacis A; Fergusson D
Cochrane Database Syst Rev; 2001; (2):CD001884. PubMed ID: 11406016
[TBL] [Abstract][Full Text] [Related]
13. Fibrin sealants or cell saver eliminate the need for autologous blood donation in anemic patients undergoing primary total knee arthroplasty.
Bou Monsef J; Buckup J; Waldstein W; Cornell C; Boettner F
Arch Orthop Trauma Surg; 2014 Jan; 134(1):53-8. PubMed ID: 24190654
[TBL] [Abstract][Full Text] [Related]
14. Does fibrin sealant use in total knee replacement reduce transfusion rates? A non-randomised comparative study.
Massin P; Scemama C; Jeanrot C; Boyer P
Orthop Traumatol Surg Res; 2012 Apr; 98(2):180-5. PubMed ID: 22405589
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of the use of surgical sealants for suture-hole bleeding in arterial anastomoses.
Rogers AC; Turley LP; Cross KS; McMonagle MP
Br J Surg; 2016 Dec; 103(13):1758-1767. PubMed ID: 27714778
[TBL] [Abstract][Full Text] [Related]
16. Is the newest fibrin sealant an effective strategy to reduce blood loss after total knee arthroplasty? A randomized controlled study.
Randelli F; D'Anchise R; Ragone V; Serrao L; Cabitza P; Randelli P
J Arthroplasty; 2014 Aug; 29(8):1516-20. PubMed ID: 24674732
[TBL] [Abstract][Full Text] [Related]
17. Fibrin Sealants in Dura Sealing: A Systematic Literature Review.
Esposito F; Angileri FF; Kruse P; Cavallo LM; Solari D; Esposito V; Tomasello F; Cappabianca P
PLoS One; 2016; 11(4):e0151533. PubMed ID: 27119993
[TBL] [Abstract][Full Text] [Related]
18. Cell salvage for minimising perioperative allogeneic blood transfusion.
Carless PA; Henry DA; Moxey AJ; O'Connell D; Brown T; Fergusson DA
Cochrane Database Syst Rev; 2010 Mar; (3):CD001888. PubMed ID: 20238316
[TBL] [Abstract][Full Text] [Related]
19. The efficiency and safety of fibrin sealant for reducing blood loss in primary total hip arthroplasty: A systematic review and meta-analysis.
Wang Z; Xiao L; Guo H; Zhao G; Ma J
Int J Surg; 2017 Jan; 37():50-57. PubMed ID: 27939268
[TBL] [Abstract][Full Text] [Related]
20. An update on topical haemostatic agents in liver surgery: systematic review and meta analysis.
Brustia R; Granger B; Scatton O
J Hepatobiliary Pancreat Sci; 2016 Oct; 23(10):609-621. PubMed ID: 27580747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
